The study looked at how many people with early-stage breast cancer have harmful gene changes in BRCA1 or BRCA2. The researchers wanted to know how these gene changes affect the patients' health and use of healthcare resources. They found that not many patients with early-stage breast cancer have these gene changes, but those who do tend to have worse outcomes. They also use more healthcare resources compared to patients without these gene changes.